General Session III and Award Presentations (104)

The AAPM 34th Annual Meeting Saturday program will kick off with a truly must-attend plenary program featuring guest speaker Vanila Singh, MD, Chief Medical Officer for HHS. Dr. Singh practices at Stanford University where she is Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine. AAPM Past President and Stanford University Redlich Professor of Anesthesiology, Perioperative and Pain Medicine, Sean Mackey, MD PhD, will also present during this session.

The Patient Advocacy Award and Presidential Excellence Award for Education will be presented.

The National Strategy and U.S. Task Force on Pain and Opioids

The U.S. Department of Health and Human Services Chief Medical Officer, Dr. Vanila M. Singh, will discuss the National Pain Strategy; her leadership in developing the U.S. Task Force on Pain and Opioids; and the ongoing mission, challenges, and opportunities to address the dual crises facing the country.

Moderator: Sean Mackey, MD PhD

Shared Solutions for Our Pain and Opioid Crises

Sean Mackey, MD PhD

The National Strategy and U.S. Task Force on Pain and Opioids

Vanila M. Singh, MD

11:30 am–12:30 pm Saturday, April 28

CDC Guideline: Where Do We Stand? Advocating for Physicians and Their Patients in Pain (304)

This session provides an update on the CDC Guideline, opioid regulatory issues, and the impact upon both patients in pain and their treating physicians. Speakers from the AMA Opioid Task Force, AAPM’s CDC Guideline project and Opioid Advisory Committee will provide their points of view followed by an interactive session with the goal of improving attendee and speaker perspectives on the intended, and unintended, consequences of the CDC Guidelines and resultant regulations.

Moderator and Introduction

Steven R. Hanling, MD

A GPS for a Maze of Guidelines and Regulations

Patrice A. Harris, MD MA CDC

Opioid Guideline: Lost in Translation

Kurt Kroenke, MD

3:30-4:30 pm Saturday, April 28

Walking the Line in Pain and the Law: Organized Medicine, Pain Physicians, and AAPM’s Work to Support Providers and Patients (312)

How do the regulatory and legal system risk infringing upon the very practice of medicine? This session will discuss how broad-based legislation in a “one size fits all” capacity impacts individualized and personalized practice—and how this approach has changed physician practice even when opioids aren’t part of the picture.

One Physician’s Story

Lynn R. Webster, MD

AAPM and the AMA: Organized Medicine’s Response to Protect Physicians and Patients

Robert E. Wailes, MD

How the State of Washington Applies the Law: The Frank Li Case. How Does This Apply to Me?

Micah T. Matthews, MPA CPM

Learning Objectives:

  • Review reasons why prosecutors will bring charges against a physician.
  • Examine processes that will mitigate the possibility of prosecution.
  • Discuss the steps a clinician should take if they are being investigated.
7–7:50 am Sunday, April 29

General Session IV (105)

The final AAPM 34th Annual Meeting plenary sessions will focus on the late-breaking findings of consensus guidelines about the use of ketamine for acute and chronic pain.

Guidelines for the Use of Ketamine to Treat Acute and Chronic Pain

An expert panel will offer insight into key findings on indications for the use of ketamine, optimal dosing, physiological monitoring, and contraindications from a newly developed clinical guideline.

Ketamine: Development of the ASRA, AAPM, and ASA Guidelines for Chronic Pain Recommendations for Use

Stephen P. Cohen, MD

Pre-Treatment Testing and Monitoring for Ketamine Infusions

Robert W. Hurley, MD PhD

Contraindications for Ketamine Infusions

Ajay D. Wasan, MD MSc

Clinical Indications and Treatment Effects of Ketamine for Chronic Pain

W. Michael Hooten, MD

Learning Objectives:

  • Identify patient subgroups where ketamine use is indicated.
  • Select optimal dose and duration of ketamine administration for acute and chronic pain.
  • Demonstrate working knowledge about which physiological monitors are needed to safely administer ketamine.
Subscribe to this RSS feed